KR900005255B1 - The process for preparation n-(3-(3-(1-pyperidinyl methyl)phenoxy)propyl)acetoxy acetamide - Google Patents

The process for preparation n-(3-(3-(1-pyperidinyl methyl)phenoxy)propyl)acetoxy acetamide Download PDF

Info

Publication number
KR900005255B1
KR900005255B1 KR1019860004198A KR860004198A KR900005255B1 KR 900005255 B1 KR900005255 B1 KR 900005255B1 KR 1019860004198 A KR1019860004198 A KR 1019860004198A KR 860004198 A KR860004198 A KR 860004198A KR 900005255 B1 KR900005255 B1 KR 900005255B1
Authority
KR
South Korea
Prior art keywords
phenoxy
formula
compound
propyl
piperidinylmethyl
Prior art date
Application number
KR1019860004198A
Other languages
Korean (ko)
Other versions
KR870011119A (en
Inventor
껜유 시바따
도시히사 이따야
노부아끼 야마고시
시게루 구라다
나오유끼 고이즈미
Original Assignee
데이고꾸조오끼 세이야꾸 가부시끼가이샤
야마구찌 에이이찌
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이고꾸조오끼 세이야꾸 가부시끼가이샤, 야마구찌 에이이찌 filed Critical 데이고꾸조오끼 세이야꾸 가부시끼가이샤
Priority to KR1019860004198A priority Critical patent/KR900005255B1/en
Publication of KR870011119A publication Critical patent/KR870011119A/en
Application granted granted Critical
Publication of KR900005255B1 publication Critical patent/KR900005255B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Abstract

N-[3-[3-(1-piperidinylmethyl)phenoxy propyl -acetoxyacetamide of formula (I) is prepd. by reacting a cpd. of formula (II) with acetoxyacetyl chloride. (II) is prepd. by the reaction of 3- (1piperidinylmethyl)-phenol and acrylonitrile and hydrogenation of the optd. cpd. (I) is useful as an ulcer treatmetn agent.

Description

N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드 염산염의 제조방법Method for preparing N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide hydrochloride

본 발명은 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드 염산염의 제조방법에 대한 것이다.The present invention relates to a process for the preparation of N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide hydrochloride.

더욱 상세하게는 , 본 발명은 항궤양제로서 유용한 하기 식(Ⅰ)In more detail, the present invention is formula (I)

Figure kpo00001
Figure kpo00001

로 표시되는 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드의 염산염을 고수율로 제조하기 위한 개량된 방법에 관한 것이다.It relates to an improved process for producing a hydrochloride of N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide represented by

상기 식(Ⅰ)의 화합물은 강력한 항궤양 작용을 갖는 물질로 본 발명자들이 신규로 개발한 화합물로서 그 합성법, 약리효과 들은 일본국 특개소 제 56-115750 호에 기재되어 있다. 상기 공개특허 공보에 의하면, 상기 식 (Ⅰ)의 화합물은 하기 식(Ⅱ)The compound of formula (I) is a compound having a strong anti-ulcer action, a compound newly developed by the present inventors, and its synthesis and pharmacological effects are described in Japanese Patent Laid-Open No. 56-115750. According to the above publication, the compound of formula (I) is represented by the following formula (II)

Figure kpo00002
Figure kpo00002

로 나타내는 3-[3-(1-피페리디메틸)페녹시]프로필아민을 히드록시 초산과 반응시켜 하기식 (Ⅲ)3- [3- (1-piperidimethyl) phenoxy] propylamine represented by the following reaction with hydroxy acetic acid gives the following formula (III)

Figure kpo00003
Figure kpo00003

의 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]하드록시아세트아미드를 생성시키고 ,계속하여 상기식 (Ⅲ)의 아미드를 유리 염기 상태에서 무수 초산으로 처리하여 아세틸화 함으로서 제조되고 있다. (상기 공개특허 공보의 실시예 3 참조.)N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] hydroxyacetamide was produced, followed by treating the amide of formula (III) with acetic anhydride in the free base state to acetyl. It is manufactured by making. (See Example 3 of the above published patent publication.)

그러나, 이 공개 특허 공보에 기재된 방법에 의하면, 상기 식 (Ⅰ)의 화합물은 상기 식 (Ⅱ)의 아민으로부터 합계 수율 69.8%로 얻어진데 불과하다.However, according to the method described in this publication, the compound of formula (I) is only obtained in a total yield of 69.8% from the amine of formula (II).

또한 이의 염산염을 의약에 제공할 수 있는 순도 (적어도 99.5% 이상)까지 정제하고자 하면, 최종제품의 식 (Ⅰ)의 화합물의 염산염의 수율은 약 50% 정도로 낮아지게 되므로 공업적으로 만족할만 하다고 볼 수 없다.In addition, if the hydrochloride is to be purified to the purity (at least 99.5% or more) that can be provided to the pharmaceutical, the yield of the hydrochloride of the compound of formula (I) of the final product is about 50%, which is industrially satisfactory. Can't.

이와 같은 결점이 없는 식(Ⅰ)의 화합물의 염산염의 공업적 제조법으로서, 본 발명자들은 먼저, N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]하드록시아세트아미드의 옥살산염을 무수 초산으로 아세틸화하고, 생성되는 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드를 분리함이 없이 그대로, 이 옥살산염에 대하여 거의 등몰량의 염화수소로 처리하고, 생성되는 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드 염산염을 분리함으로서 고순도의 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드 염산염을 고수율로 제조하는 방법을 제안하였다. (한국 특허 출원 공개 제 2364/1984호 , 대만특허 제 19061호)As an industrial preparation method for the hydrochloride of the compound of formula (I) without such a drawback, the present inventors firstly prepared N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] hydroxyacetamide. The oxalate was acetylated with acetic anhydride, and the resultant N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide was used as it was, almost without being isolated. Treatment with an equimolar amount of hydrogen chloride and separation of the resultant N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide hydrochloride to remove N- [3- [3- ( A method for preparing 1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide hydrochloride in high yield was proposed. (Korean Patent Application Publication No. 2364/1984, Taiwan Patent No. 19061)

그러나 상기 제안의 방법은 2공정의 방법으로서, 더 개량할 여지가 남아 있다.However, the proposed method is a two-step method, and there is room for further improvement.

이번 본 발명에 있어, 3-[3-(1-피페리디메틸)페녹시]프로필아민을 아세톡시아세틸 클로라이드와 반응시킴으로서 1공정에 목적하는 식(Ⅰ)의 화합물의 염산염을 수율이 양호하게 제조할 수 있음을 발견하였다.In the present invention, the hydrochloride of the compound of formula (I) desired in one step is produced in a good yield by reacting 3- [3- (1-piperidimethyl) phenoxy] propylamine with acetoxyacetyl chloride. I found it possible.

그리하여 , 본 발명에 의하면 3-[3-(1-피페리디메틸)페녹시 ]프로필아민[상기식 (Ⅱ)의 화합물]을 아세톡시아세틸클로라이드와 반응시킴을 특징으로 하는 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드 염산염 [상기식(Ⅰ)의 화합물의 염산염]의 제조방법이 제공된다.Thus, according to the present invention, N- [3- [characterized by reacting 3- [3- (1-piperidimethyl) phenoxy] propylamine [compound of formula (II)] with acetoxyacetylchloride. A method for producing 3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide hydrochloride [hydrochloride of a compound of formula (I)] is provided.

일반식 (Ⅱ)의 화합물과 아세톡시아세틸클로라이드와의 반응은 통상 불활성 용매중, 예를 들면 클로로포름, 디클로로메탄, 초산에틸 등 중에서, 약 50도내지 반응 혼합물의 환류온도, 바람직하기는 반응 혼합물의 환류 온도에 있어 행할 수가 있다.The reaction of the compound of formula (II) with acetoxyacetyl chloride is usually carried out at about 50 degrees to the reflux temperature of the reaction mixture, preferably in the reaction mixture, in an inert solvent such as chloroform, dichloromethane, ethyl acetate, and the like. It can be performed at the reflux temperature.

상기 반응에 있어서, 일반식 (Ⅱ)의 화합물에 대한 아세톡시아세틸클로라이드의 사용비율은 엄밀히 제한되는 것은 아니며, 사용하는 용매의 종류나 반응 온도 등에 의하여 변경할 수가 있는데, 일반적으로는 거의 등몰 양으로서 바람직하기는 0.95~1.0 몰의 비율로 사용하는 것이 적당하다.In the above reaction, the ratio of the use of acetoxyacetyl chloride to the compound of the general formula (II) is not strictly limited, and may be changed depending on the type of solvent used, the reaction temperature, and the like. The following is suitably used in the ratio of 0.95-1.0 mol.

상기 반응은 탄염화수소 반응으로서, 반응의 결과 유리되는 염화 수소는 생성되는 일반식 (Ⅰ)의 화합물과 염을 생성하며 그 결과 , 일반식 (Ⅰ)의 화합물의 염산염이 직접 얻어진다. 그 결과 얻어지는 일반식 (Ⅰ)의 화합물의 염산염은 공지의 방법, 예를 들면 여과, 재결정 등의 방법에 의하여 반응 혼합물로부터 유리되며, 필요에 의하여 다시 정제할 수도 있다.The reaction is a hydrogen chloride reaction, in which the hydrogen chloride liberated as a result of the reaction produces a compound and a salt of the general formula (I), whereby the hydrochloride of the compound of the general formula (I) is obtained directly. The resulting hydrochloride of the compound of general formula (I) is liberated from the reaction mixture by a known method such as filtration, recrystallization or the like, and may be purified again if necessary.

상기 방법에 있어, 출발 원료로서 사용되는 식(Ⅱ)의 화합물은 공지의 화합물로서 , 예를 들면 전술의 일본의 특개소 56-11570 호 공개 특허 공보에 기재된 방법에 의하여 합성할 수가 있는데 , 본 발명자들이 개발한 다음 반응식 (Α)로 나타내는 방법에 의하여도 합성할 수가 있다.In the above method, the compound of formula (II) to be used as a starting material can be synthesized as a known compound, for example, by the method described in the above-mentioned Japanese Patent Application Laid-Open No. 56-11570. They can also be synthesized by the method shown by the following reaction formula (Α).

[반응식 A]Scheme A

Figure kpo00004
Figure kpo00004

상기 반응식 (A)에 있어, 일반식 (Ⅳ)의 화합물과 아크릴로니트릴[일반식 (Ⅴ)의 화합물]과의 반응은, 통상, 용매의 부재하에 아크릴로니트릴을 매우 과량으로 사용하여 수행 할 수가 있다. 이 반응은 페놀성 OH에 대한 올레핀성 2중 결합의 부가 반응으로서, 일반적으로, 수소화나트륨, 수산화나트륨 등의 촉매의 존재하에서 수행하는 것이 유리하다.In the above reaction formula (A), the reaction between the compound of formula (IV) and acrylonitrile [compound of formula (V)] is usually carried out using a very excessive amount of acrylonitrile in the absence of a solvent. There is a number. This reaction is an addition reaction of olefinic double bonds to phenolic OH, which is generally advantageously carried out in the presence of a catalyst such as sodium hydride, sodium hydroxide and the like.

이와 같은 촉매의 사용량은 , 식(Ⅳ)의 화합물 1몰당 1/50~1/5 몰의 범위 내가 적당하다. 또 상기 부가반응은 일반적으로 약 50도 내지 반응 혼합물의 환류온도, 특히 반응 혼합물의 환류 온도에서 실시하는 것이 적합하다.The usage-amount of such a catalyst is suitable in the range of 1 / 50-1 / 5 mol per mol of a compound of Formula (IV). The addition reaction is generally suitably carried out at about 50 degrees to the reflux temperature of the reaction mixture, in particular at the reflux temperature of the reaction mixture.

이와 같이 일반식(Ⅳ)의 화합물이 생성되며, 필요에 따라서 바람직하기는 예를 들면 추출 등에 의하여 분리한 후, 수소가 첨가된다. 식 (Ⅳ)의 화합물의 수소 첨가는 통상, 반응에 불활성인 용매, 예를 들면 메탄올, 에탄올, 벤젠, 테트라히드로푸란, 에틸에테르, 디메톡시에탄 등 중에서 (a) 예를 들면 라니 니켈, 팔라듐- 탄소 등의 수소첨가 촉매의 존재하에 통상, 상온에서, 상압, 또는 가압하면서 수소와 반응시키거나, (b) 예를 들면, 수소화리튬 알루미늄 등의 금속수소화합물과 빙냉하 내지 반응 혼합물의 환류 온도에 반응시킴으로써 행할 수 있다. 그리고 상기 (b)에 있어서 금속 수소화합물의 사용량은 일반적으로 식(Ⅵ)의 화합물 1몰당 0.5~ 10몰 , 바람직하기는 1~2 몰이 적당하다.Thus, the compound of general formula (IV) is produced | generated, Preferably it isolate | separates by extraction etc. as needed, and hydrogen is added. The hydrogenation of the compound of formula (IV) is usually carried out in a solvent inert to the reaction, for example methanol, ethanol, benzene, tetrahydrofuran, ethyl ether, dimethoxyethane, or the like (a) for example Raney nickel, palladium- In the presence of a hydrogenation catalyst such as carbon, it is usually reacted with hydrogen at normal pressure or under pressure at normal temperature, or (i) at a reflux temperature of a metal hydrogen compound such as lithium aluminum hydride and the like under ice-cooling to the reaction mixture. It can be performed by making it react. In the above (iv), the amount of the metal hydrogen compound is generally 0.5 to 10 mol, preferably 1 to 2 mol, per mol of the compound of formula (VI).

상기 수소첨가에 의하여 식(Ⅱ)의 화합물이 얻어지는데, 이 화합물은 공지의 방법에 의하여 분리 정제한 후 , 전술의 본 발명의 방법에 제공할 수가 있다.The compound of formula (II) is obtained by the hydrogenation, which can be provided to the above-described method of the present invention after separation and purification by a known method.

이상 설명한 발명의 방법에 의하면, 항궤양제로서 유리한 식(Ⅰ)의 화합물의 염산염을, 75% 이상의 고수율 [전기 식 (Ⅳ)의 페놀로부터의 합계 수율]로 제조할 수가 있으므로, 공익적으로 극히 유리하다.According to the method of the invention described above, hydrochloride of the compound of formula (I), which is advantageous as an anti-ulcer agent, can be produced in a high yield of 75% or more [total yield from phenol of the formula (IV)]. Extremely advantageous.

다음의 실시예에 의하여 본 발명을 더 상세히 설명한다.The present invention is explained in more detail by the following examples.

[실시예]EXAMPLE

3-(1-피페리디닐메틸)페놀 4g 을 수소화나트륨 40㎎의 존재하에서 아크릴로니트릴 15㎖와 함께 18시간동안 가열 환류하였다. 반응 혼합물을 물에 넣고 벤젠으로 추출하였다. 벤젠층을 수산화나트륨 수용액으로 세정하고, 수세한 후 건조하였다. 용매를 증류시켜 유상의 3-[3-(1-피페리디메틸)페녹시 ]프로피오니트릴 4.75 g을 얻는다. 수율 :93.3%4 g of 3- (1-piperidinylmethyl) phenol was heated to reflux for 18 hours with 15 ml of acrylonitrile in the presence of 40 mg of sodium hydride. The reaction mixture was poured into water and extracted with benzene. The benzene layer was washed with aqueous sodium hydroxide solution, washed with water and dried. The solvent is distilled off to obtain 4.75 g of an oily 3- [3- (1-piperidimethyl) phenoxy] propionitrile. Yield: 93.3%

NMR(CDCL₃,δ): 1.2~1.8(6H, 다중선), 2.2~.2.6(4H, 다중선),2.78(2H, 삼중선, J=6H z), 3.42(2H, 단일선), 4.15(2H, 삼중선,J=6Hz), 6.6~7.4(4H, 다중선).NMR (CDCL3, δ): 1.2 to 1.8 (6H, multiplet), 2.2 to 2.6.4 (4H, multiplet), 2.78 (2H, triplet, 6 = 6HV), 3.42 (2H, singlet), 4.15 (2H, triplet, J = 6HV), 6.6-7.4 (4H, multiplet).

위에서 얻은 프로피오니트릴 4.7g울 에탄올 23.5㎖에 용해하고 , 라니니켈 1.4g의 존재하에 실온에서 수소첨가하였다. 등몰의 수소가 소비된 후, 촉매를 제거하고, 벤젠으로 추출하였다. 벤젠층을 4% 수산화나트륨 수용액으로 세정하고, 수세후 건조하였다. 용매를 증류시켜 유상의 3-[3-(1-피페리디메틸)페녹시 ]프로필아민 4.5g을 얻는다. 수율 93.8%4.7 g of propionitrile obtained above was dissolved in 23.5 ml of ethanol and hydrogenated at room temperature in the presence of 1.4 g of Ranickel. After equimolar hydrogen has been consumed, the catalyst is removed and extracted with benzene. The benzene layer was washed with 4% aqueous sodium hydroxide solution and dried after washing with water. The solvent is distilled off to obtain 4.5 g of oily 3- [3- (1-piperidimethyl) phenoxy] propylamine. Yield 93.8%

NMR(CDCℓ₃,δ):1.3~1.7(6H, 다중선), 1.95(2H, 사중선,J=6Hz),2.2~2.6(4H, 다중선), 2.88(2H, 삼중선,J=6Hz), 3.42(2H, 단일선), 4.02(2H, 삼중선,J=6Hz), 6.6~7.4(4H, 다중선),NMR (CdCℓ₃, δ): 1.3 to 1.7 (6H, multiplet), 1.95 (2H, quadruple, J = 6Hz), 2.2 to 2.6 (4H, multiplet), 2.88 (2H, triplet, J = 6Hz) , 3.42 (2H, singlet), 4.02 (2H, triplet, J = 6Hz), 6.6 to 7.4 (4H, multiplet),

위에서 얻은 프로필아민 4.5g을 클로로포름 20㎖에 용해하고, 가열 환류하면서 아세톡시아세틸클로라이드 2.47g을 적가하였다. 반응 혼합물을 2시간 가열 환류한 후, 초산에틸을 가하고, 실온에서 냉각하면, 백색 결정이 석출된다.4.5 g of propylamine obtained above was dissolved in 20 ml of chloroform, and 2.47 g of acetoxyacetyl chloride was added dropwise while heating to reflux. After the reaction mixture was heated to reflux for 2 hours, ethyl acetate was added and cooled to room temperature to precipitate white crystals.

이 결정을 여과하고 , 건조하여, N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드 염산염 6.2g을 얻는다. 수율89.0% 융점 147℃This crystal is filtered and dried to obtain 6.2 g of N- [3- [3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide hydrochloride. Yield 89.0% Melting Point 147 ℃

Claims (2)

하기 일반식 (Ⅱ)의 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필아민을 아세톡시아세틸클로라이드와 반응시킴을 특징으로 하기 일반식(Ⅰ)로 표시되는 N-[3-[3-(1-피페리디닐메틸)페녹시]프로필]아세톡시아세트아미드 염산염의 제조방법.N- represented by the following general formula (I) characterized by reacting N- [3- [3- (1-piperidinylmethyl) phenoxy] propylamine of the following general formula (II) with acetoxyacetyl chloride: A process for preparing [3- [3- (1-piperidinylmethyl) phenoxy] propyl] acetoxyacetamide hydrochloride.
Figure kpo00005
Figure kpo00005
제1항에 있어서 3-[3-(1-피페리디메틸)페녹시]프로필아민은 3-(1-피페리디닐메틸) 페놀을 아크릴로니트릴과 반응시켜 얻어지는 3-[3-(1-피페리디닐메틸)페녹시 ]프로피오니트릴을 수소 첨가함으로서 제조하는 방법.The 3- [3- (1-piperidinyl) phenoxy] propylamine is obtained by reacting 3- (1-piperidinylmethyl) phenol with acrylonitrile. A process for producing piperidinylmethyl) phenoxy] propionitrile by hydrogenation.
KR1019860004198A 1986-05-28 1986-05-28 The process for preparation n-(3-(3-(1-pyperidinyl methyl)phenoxy)propyl)acetoxy acetamide KR900005255B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019860004198A KR900005255B1 (en) 1986-05-28 1986-05-28 The process for preparation n-(3-(3-(1-pyperidinyl methyl)phenoxy)propyl)acetoxy acetamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019860004198A KR900005255B1 (en) 1986-05-28 1986-05-28 The process for preparation n-(3-(3-(1-pyperidinyl methyl)phenoxy)propyl)acetoxy acetamide

Publications (2)

Publication Number Publication Date
KR870011119A KR870011119A (en) 1987-12-21
KR900005255B1 true KR900005255B1 (en) 1990-07-21

Family

ID=19250178

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860004198A KR900005255B1 (en) 1986-05-28 1986-05-28 The process for preparation n-(3-(3-(1-pyperidinyl methyl)phenoxy)propyl)acetoxy acetamide

Country Status (1)

Country Link
KR (1) KR900005255B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030079456A (en) * 2002-04-04 2003-10-10 바이오네스트 주식회사 A process for the preparation of roxatidine acetate or pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
KR870011119A (en) 1987-12-21

Similar Documents

Publication Publication Date Title
US5434304A (en) Process for preparing formoterol and related compounds
JPWO2003097632A1 (en) Propanolamine derivative, method for producing 3-N-methylamino-1- (2-thienyl) -1-propanol, and method for producing propanolamine derivative
HU186776B (en) Process for preparing new, optically active imidazolidin-2-one derivatives
KR840001071B1 (en) Process for the preparation of 9- carbanoyl-9-(2-cyanoethyl)fluorenes
SU493958A3 (en) The method of obtaining derivatives of 1-phenoxy-aminopropane 2-ol
EP0002978B1 (en) Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
US4978793A (en) Novel process for the preparation of serinol
KR900005255B1 (en) The process for preparation n-(3-(3-(1-pyperidinyl methyl)phenoxy)propyl)acetoxy acetamide
WO1996004232A1 (en) Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
KR820002345B1 (en) Process for preparing 2,2-(ethylene diamino)-dibutanol-diisoniazid-methane sulfonate
JP2001521498A (en) Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide
US4906773A (en) Process for preparing optically active threonine
KR0163042B1 (en) Process for the preparation of 4-amino-5-hexenic acids
US4189595A (en) [N-benzyl-o-(2,6-dichloroanilino)phenyl]acetic acid derivatives
US4831167A (en) Process for diastereoselective reduction of 3-amino-1-benzoxepin-5(2H)-ones
JPS60252441A (en) Naphthalene and naphthoquinone derivative
JP2810465B2 (en) Method for producing N-methyl-4-t-butylbenzylamine
CH651031A5 (en) PROCESS FOR THE PREPARATION OF (TRIALCOXY BENZYL) -1 PIPERAZINES.
KR100305152B1 (en) Manufacturing method of C-substituted diethylene triamine
CA2012342A1 (en) Platinum-derived complexes, their preparation and pharmaceutical compounds containing them
JP2767287B2 (en) Indole production method
US4709086A (en) Process for the preparation of 4-benzyl aspartate
US4189444A (en) Process for the preparation of N,N'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein
CA1067099A (en) Process for the production of substituted benzyl cyanides
KR800001450B1 (en) Process for the preparation of 1,3,5-trisubstitude benzene derivative

Legal Events

Date Code Title Description
A201 Request for examination
J204 Request for invalidation trial [patent]
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050616

Year of fee payment: 16

EXPY Expiration of term